Article
Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.
Biochemical pharmacology - 1 Oct 2000
Kraker A J, Hartl B G, Amar A M, Barvian M R, Showalter H D, Moore C W
Abstract excerpt
Increased expression or activity of c-Src tyrosine kinase has been associated with the transformed phenotype in tumor cells and with progression of neoplastic disease. A number of pyrido[2, 3-d]pyrimidines have been characterized biochemically and in cells as part of an assessment of their potential as anti-tumor agents. The compounds were ATP-competitive inhibitors of c-Src kinase with IC(50) values < 10 nM and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
